logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Ronac Mamtani

University of Pennsylvania

45H指数
341论文数
1.1W被引数
收录论文 105
发表时间
logo
Severe primary organ-related complications in patients with de novo metastatic cancer: implications for prophylactic local therapy新发转移性癌症患者中严重原发性器官相关并发症：预防性局部治疗的启示
errClinical and Translational Radiation Oncology
IF2.7
err2026-07-17
err0
errOAAI
errHefei Liu; Dafna Merhav; Naia Tabakovic; Ronac Mamtani; Karishma Khullar; John Christodouleas
err分享
err收藏
PERFORMANCE OF A COMPUTATIONAL HISTOLOGY ARTIFICIAL INTELLIGENCE (CHAI) PROGNOSTIC BIOMARKER IN MUSCLE INVASIVE BLADDER CANCER (MIBC)计算组织学人工智能(CHAI)预后生物标志物在肌肉浸润性膀胱癌(MIBC)中的性能
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errLotan, Yair; Margulis, Vitaly; Woldu, Solomon; Allison, Derek; Kim, Joon Kyung; Bukavina, Laura; Chang, Sam; Kamat, Ashish; Stewart, Tyler; Mamtani, Ronac; Efstathiou, Jason; Miyamoto, David; Krishna, Vrishab; Kaul, Gaurav; Zhang, Haochen; Abuzeid, Waleed; Royce, Trevor; Krishna, Viswesh; Joshi, Anirudh; Li, Roger; Hensley, Patrick
err分享
err收藏
Outcomes of enfortumab vedotin plus pembrolizumab in patients with advanced urothelial cancer and severe renal dysfunction恩诺单抗偶联物联合帕博利珠单抗在伴有严重肾功能不全的晚期尿路上皮癌患者中的疗效
errUrologic Oncology-Seminars and Original Investigations
IF2.3
err2026-01-01
err0
errOAAI
errLitt, Henry K.; Mamtani, Ronac; Chow, Ryan D.
err分享
err收藏
Real-World Enfortumab Vedotin ± Pembrolizumab Treatment-Based Toxicities and Associations With Survival in Advanced Urothelial Carcinoma真实世界恩福妥单抗联合/不联合帕博利珠单抗治疗相关毒性与晚期尿路上皮癌患者生存期的关联
errClinical Genitourinary Cancer
IF2.7
err2026-01-01
err0
errOAAI
errKurian, Martin; Mamtani, Ronac; Elghawy, Omar; Nimgaonkar, Vivek
err分享
err收藏
Treatment Patterns, Disease Recurrence, and Overall Survival in Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy: A Population-Level Claims-Based AnalysisSquires, P.; Cook, E.E.; Song, Y.; Wang, C.-Y.; Zhang, A.; Seshasayee, S.M.; Rogiers, A.; Li, H.; Mamtani, R. 肌肉浸润性膀胱癌患者在根治性膀胱切除术后：治疗模式、疾病复发与总生存期——一项基于人群索赔数据的分析。Clin. Genitourin. Cancer 2026, 24, 102466. [Google Scholar] [CrossRef]
errClinical Genitourinary Cancer
IF2.7
err2025-12-01
err0
PREAI
errSquires, Patrick; Cook, Erin E.; Song, Yan; Wang, Ching-Yu; Zhang, Adina; Seshasayee, Shravanthi M.; Rogiers, Aljosja; Li, Haojie; Mamtani, Ronac
err分享
err收藏
Association Between Early on-Treatment Weight Loss With Enfortumab Vedotin Plus Pembrolizumab and Survival in Advanced Urothelial Carcinoma早期治疗期间体重减轻与恩沃夫单抗 vedotin 联合帕博利珠单抗在晚期尿路上皮癌中的生存关系
errClinical Genitourinary Cancer
IF2.7
err2025-11-01
err0
errOAAI
errChow, Ryan D.; Mamtani, Ronac
err分享
err收藏
Considerations for emulations of randomized controlled trials using real-world data: learnings from an emulation of MONALEESA-2
errJournal of Comparative Effectiveness Research
IF2.5
err2025-11-01
err0
PREAI
errKong, Amanda M.; Andrean, Dionna; Khan, Saarah; Choi, Julia; Mamtani, Ronac; Parikh, Ravi; Jaksa, Ashley; Campbell, Ulka
err分享
err收藏
Cost-effectiveness of enfortumab vedotin plus pembrolizumab as a first-line treatment of locally advanced or metastatic urothelial carcinoma in the United States恩沃利单抗 vedotin 联合帕博利珠单抗作为美国局部晚期或转移性尿路上皮癌一线治疗的成本效益分析
errJournal of Medical Economics
IF3
err2025-10-14
err0
errOAAI
errYang Meng; Shujing Zhang; Mounir Aout; Aram Babcock; Haojie Li; Yizhen Lai; Sarah Brand-Wiita; Spencer Notinger; Abhi Bavle; Ronac Mamtani
err分享
err收藏
Assessment of synergistic vs. independent drug activity for enfortumab vedotin and pembrolizumab in untreated advanced urothelial carcinoma评估恩沃利单抗 vedotin 与帕博利珠单抗在未治疗晚期尿路上皮癌中的协同作用与独立药物活性
errUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
err2025-09-01
err0
errOAAI
errChow, Ryan D.; Mamtani, Ronac
err分享
err收藏
Off-Label Use of Checkpoint Inhibitors in Patients With Negative or Unknown PD-L1 Status in Advanced Head and Neck Cancer在PD-L1状态为阴性或未知的晚期头颈癌患者中，超说明书使用免疫检查点抑制剂
errJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
err2025-02-11
err0
PREAI
errStalker, Margaret; Qu, Kewen; Cohen, Roger B.; Mamtani, Ronac; Hwang, Wei-Ting; Sun, Lova
err分享
err收藏
Evolving racial/ethnic disparities in AML survival in the novel therapy era新型疗法时代急性髓系白血病（AML）生存率的种族/族裔差异演变
errBLOOD ADVANCES
IF7.1
err2025-01-31
err1
PREAI
errWang, Xin; Gimotty, Phyllis A.; Matthews, Andrew H.; Mamtani, Ronac; Luger, Selina M.; Hexner, Elizabeth O.; V. Babushok, Daria; Mccurdy, Shannon R.; V. Frey, Noelle; Bruno, Ximena Jordan; Gill, Saar; Martin, Mary Ellen; Paralkar, Vikram R.; Maillard, Ivan; Porter, David L.; Loren, Alison W.; Perl, Alexander E.; Pratz, Keith W.; Getz, Kelly D.; Lai, Catherine
err分享
err收藏
Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations利用基于机器学习的试验模拟评估肿瘤学试验结果对真实世界患者的普适性
errNATURE MEDICINE
IF50
err2025-01-03
err0
errOAAI
errOrcutt, Xavier; Chen, Kan; Mamtani, Ronac
err分享
err收藏
Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2024-12-03
err0
PREAI
errReibel, Jacob B.; Sun, Lova L.; Parikh, Ravi B.; Mahmud, Nadim; Martin, Lainie P.; Hubbard, Rebecca A.; Mamtani, Ronac
err分享
err收藏
Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer
errEUROPEAN UROLOGY
IF25.2
err2024-11-01
err0
PREAI
errMamtani, Ronac; Ulloa-Perez, Ernesto; Parikh, Ravi B.; Patel, Khilna; Moreno, Blanca Homet; Ramamurthy, Chethan; Li, Haojie; Hubbard, Rebecca A.
err分享
err收藏
Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023
errJNCI CANCER SPECTRUM
IF4.1
err2024-09-13
err3
errOAAI
errGuadamuz, Jenny S.; Wang, Xiaoliang; Altomare, Ivy; Castillo, Wendy Camelo; Sarkar, Somnath; Mamtani, Ronac; Calip, Gregory S.
err分享
err收藏
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
errJCO CLINICAL CANCER INFORMATICS
IF2.8
err2024-08-01
err2
PREAI
errBrown, Timothy J.; Gimotty, Phyllis A.; Mamtani, Ronac; Karasic, Thomas B.; Yang, Yu-Xiao
err分享
err收藏
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus ChemotherapyEV-301既往接受过治疗的晚期尿路上皮癌患者的健康相关生活质量: Enfortumab Vedotin与化疗的3期试验
errEUROPEAN UROLOGY
IF25.2
err2024-06-01
err4
errOAAI
errRosenberg, Jonathan E.; Mamtani, Ronac; Sonpavde, Guru P.; Loriot, Yohann; Duran, Ignacio; Lee, Jae-Lyun; Matsubara, Nobuaki; Vulsteke, Christof; Castellano, Daniel; Sridhar, Srikala S.; Pappot, Helle; Gurney, Howard; Bedke, Jens; van der Heijden, Michiel S.; Galli, Luca; Keam, Bhumsuk; Masumori, Naoya; Meran, Johannes; O'Donnell, Peter H.; Park, Se Hoon; Grande, Enrique; Sengelov, Lisa; Uemura, Hiroji; Skaltsa, Konstantina; Campbell, Mary; Matsangou, Maria; Wu, Chunzhang; Hepp, Zsolt; Mckay, Caroline; Powles, Thomas; Petrylak, Daniel P.
err分享
err收藏
Bladder Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines
errJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
err2024-05-01
err13
errOAAI
errFlaig, Thomas W.; Spiess, Philippe E.; Abern, Michael; Agarwal, Neeraj; Bangs, Rick; Buyyounouski, Mark K.; Chan, Kevin; Chang, Sam S.; Chang, Paul; Friedlander, Terence; Greenberg, Richard E.; Guru, Khurshid A.; Herr, Harry W.; Hoffman-Censits, Jean; Kaimakliotis, Hristos; Kishan, Amar U.; Kundu, Shilajit; Lele, Subodh M.; Mamtani, Ronac; Mian, Omar Y.; Michalski, Jeff; Montgomery, Jeffrey S.; Parikh, Mamta; Patterson, Anthony; Peyton, Charles; Plimack, Elizabeth R.; Preston, Mark A.; Richards, Kyle; Sexton, Wade J.; Siefker-Radtke, Arlene O.; Stewart, Tyler; Sundi, Debasish; Tollefson, Matthew; Tward, Jonathan; Wright, Jonathan L.; Cassara, Carly J.; Gurski, Lisa A.
err分享
err收藏
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial (vol 29, pg 2825, 2023)
errNATURE MEDICINE
IF50
err2024-01-19
err1
errOAAI
errGalsky, Matthew D.; Daneshmand, Siamak; Izadmehr, Sudeh; Gonzalez-Kozlova, Edgar; Chan, Kevin G.; Lewis, Sara; Achkar, Bassam El; Dorff, Tanya B.; Cetnar, Jeremy Paul; Neil, Brock O.; D'Souza, Anishka; Mamtani, Ronac; Kyriakopoulos, Christos; Jun, Tomi; Gogerly-Moragoda, Mahalya; Brody, Rachel; Xie, Hui; Nie, Kai; Kelly, Geoffrey; Horowitz, Amir; Kinoshita, Yayoi; Ellis, Ethan; Nose, Yohei; Ioannou, Giorgio; Cabal, Rafael; Del Valle, Diane M.; Haines, G. Kenneth; Wang, Li; Mouw, Kent W.; Samstein, Robert M.; Mehrazin, Reza; Bhardwaj, Nina; Yu, Menggang; Zhao, Qianqian; Kim-Schulze, Seunghee; Sebra, Robert; Zhu, Jun; Gnjatic, Sacha; Sfakianos, John; Pal, Sumanta K.
err分享
err收藏
The association between telemedicine, advance care planning, and unplanned hospitalizations among high-risk patients with cancer高风险癌症患者的远程医疗，预先护理计划和计划外住院之间的关联
errCANCER
IF5.1
err2023-11-21
err4
PREAI
errBange, Erin M.; Li, Yimei; Kumar, Pallavi; Doucette, Abigail; Gabriel, Peter; Parikh, Ravi; Li, Eric H.; Mamtani, Ronac; Getz, Kelly D.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jedd D. Wolchok
H 指数: 173 · 论文数: 1.4K
E
E. John Wherry
H 指数: 142 · 论文数: 640
J
Jean‐Frédéric Colombel
H 指数: 139 · 论文数: 1.4K
C
Christopher M. O’Connor
H 指数: 130 · 论文数: 968
C
Charles P. Quesenberry
H 指数: 122 · 论文数: 745
查看更多